N13: Quality of life among patients with IBD on biological treatment: does it matter if they are in remission?
ECCO '19 Copenhagen
2019
N14: Professional profile of nurses working with inflammatory bowel disease in Brazil
ECCO '19 Copenhagen
2019
N15: Microscopic colitis in two DGH, is there a clear pathway to diagnosis or treatment
ECCO '19 Copenhagen
2019
N16: The influence of children's inflammatory bowel disease (IBD) on the relationship between parents and their married life
ECCO '19 Copenhagen
2019
N17: Frequency of infliximab-induced skin lesions and their impact on quality of life in inflammatory bowel disease patients treated with infliximab
ECCO '19 Copenhagen
2019
N19: Validity of a Korean Version of inflammatory bowel disease–fatigue scale
ECCO '19 Copenhagen
2019
1
N20: Experience with therapeutic drug monitoring on adalimumab in paediatric inflammatory bowel disease (pIBD)
ECCO '19 Copenhagen
2019
1
N21: The interpretation of thiopurine metabolites in clinical practice: IBD nurses experience in three North West England NHS trusts
ECCO '19 Copenhagen
2019
1
N23: IBD patients experience of the care given at the Stockholm Gastro Centre
ECCO '19 Copenhagen
2019
1
N24: Experience with Ustekinumab (STELARA®) in Paediatric inflammatory bowel disease (pIBD) – A case series
ECCO '19 Copenhagen
2019
1
OP01: In-depth characterisation of host genetics and gut microbiome unravels novel host–microbiome interactions in inflammatory bowel disease
ECCO '19 Copenhagen
2019
OP02: The role of PTPN2 SNP in the pathogenesis of fibrosis in Crohn’s disease
ECCO '19 Copenhagen
2019
OP04: Turning sweet in inflammatory bowel disease: glycans as novel immunomodulators of T-cell-mediated immune response
ECCO '19 Copenhagen
2019
OP06: Gut–brain axis revisited: Shedding light on the mucosa-associated microbial composition in IBD patients with psychological distress, anxiety, and depression
ECCO '19 Copenhagen
2019